Welcome to AnavexTM Life Sciences Corp.

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer.


Anavex corporate presentation at Ladenburg Thalmann Healthcare Conference on Sept. 29, 2015


TheStockRadio.com speaks with Christopher Missling, PhD., President and CEO of Anavex.